In conclusion, we demonstrated that the excessive expression of FOXP3 in tumor-infiltrating CD4+ T cells of CRC patients is caused, at least in part, by the upregulation of STAT5 and TET2. This evidence concerns the gene FOXP3 and neoplasm.